Lecanemab: Breakthrough Alzheimer’s Disease Medication Déjà vu

Minding Memory

Over 20 million podcasts, powered by

Content provided by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michigan Medicine Department of Communication and Michigan Medicine Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

1+ y ago 35:52

MP3•Episode home

In this episode of Minding Memory, we dive into the newest FDA-approved drug to treat Alzheimer’s – Lecanemab – with Ohio State University stroke neurologist Jim Burke. Dr. Burke discusses the benefits and drawbacks of the new Alzheimer’s drug and also the paradigm shift of how people (clinicians, patients, and the general population) are thinking about these news Alzheimer’s medications.

Jim Burke Faculty Profile: https://wexnermedical.osu.edu/find-a-doctor/james-burke-md-128794

Article referenced in podcast: Burke JF, Richard S, Langa KM, Albin RL, Kotagal V. Lecanemab: Looking Before We Leap. Neurology. 2023 Jul 21: doi: 10.1212/WNL.0000000000207505. Epub ahead of print. PMID: 37479527.

The transcript for this episode can be found here.

CAPRA Website: http://capra.med.umich.edu/

You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts.

Hosted on Acast. See acast.com/privacy for more information.

40 episodes

#Science #Fitness #Medicine #Mental Health #Michigan Medicine Department of Communication #Michigan Medicine Podcast Network #Alzheimer's Disease #Adrd #Dementia #Dementia Researcher #University Of Michigan #Aging #Geriatrics